LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose is to compare the efficacy of treatment with LEO 90100 at Week 4 to that of
calcipotriol plus betamethasone dipropionate (BDP) gel at Week 8 in subjects with psoriasis
vulgaris